About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04858373

Characterizing Emmer Seeds and Flours, and Determining the Glycemic Effects of Emmer Breads

This study characterized emmer seeds, flours, and breads, and investigated the effects of emmer breads on the glycemic response

Lead sponsor: Agricultural University of Athens•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Agricultural University of Athens

This study aimed to 1. describe the technological characteristics of emmer seeds, flours, and breads, 2. determine the glycemic index and glycemic load of two emmer breads, and 3. to investigate the effects of these breads on postprandial glycemic response in healthy subjects

Age

18 - 25 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•healthy
•non-smoking
•non-diabetic men and women
•body mass index (BMI) between 18 and 27 kg/m2

Exclusion Criteria

•severe chronic disease (e.g. coronary heart disease, diabetes mellitus,kidney or liver conditions, endocrine conditions)
•gastrointestinal disorders
•pregnancy
•lactation
•competitive sports
•alcohol
•drug dependency

Related studies

Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

NCT06105164 · Appetitive Behavior, Obesity

Investigating the Glycaemic and Satiating Capacity of PulseOn® Enriched Foods

NCT06508424 · Glycaemic Response, Appetitive Behavior, and more

Appetite and Dietary Intake Across the Menstrual Cycle

NCT06327087 · Appetitive Behavior, Healthy, and more

Exogenous Ketones and Appetite

NCT06327464 · Appetite, Obesity, and more

Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men

NCT04237467 · Transgender, Gender Identity, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 26, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment14

Start dateAug 2019

Last updatedApr 26, 2021

Condition

Potential Abnormality of Glucose Tolerance Appetitive Behavior

Locations shown

Agricultural University of Athens

Athens, Attica

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 26, 2021Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions